Creating a Cult Following

Client

Cult Health

Industry

Health Care

Scope

Product Design
Project Managment

Creating a Cult Following: Updating FebriSol to create a 30-day medication and symptom tracking system

The Challenge: Help patients understand the causal link between treatment adherence and improved health.

Cult Health, a medical marketing firm based in Manhattan, approached Studio Fundi to contribute to a promotional pack as part of the launch of a new medication* in the United States. The Cult Health team challenged Studio Fundi to help patients understand the connection between consistently taking their medication and a reduction in the onset of symptoms.

*Due to a non-disclosure clause in Studio Fundi’s contract with Cult Health we are unfortunately not able to release the name of the medication or pharmaceutical company.

The Solution

We augmented the original version of FebriSol to incorporate symptom tracking, and accommodate a thirty-day treatment protocol. Working alongside the Cult Health team, the original design was adapted to enable patients to track and adhere to a once-daily dosing regimen and also track their symptoms.

We adapted the second scratch field on the twice-daily treatment protocol, originally reserved for an evening dose, to be a marker for when the patient felt an onset of symptoms. The original design of FebriSol allows for a twenty-eight-day prescription. The benefit of designing the system with twenty-eight days is that the patient can start on any day of the week, at any point on the sticker and loop to finish on the day before they start. However, this medication necessitated a thirty-day prescription. We experimented with two variations and, after several consultations, ultimately settled on using ‘first’ and ‘last’ day as an intuitive approach.

The Result

750 000 units of the final product were ordered and distributed to 250 000 patients in the United States. This was the first large-scale production and distribution of FebriSol.